IgD multiple myeloma - A clinical profile and outcome with chemotherapy and autologous stem cell transplantation

Keyphrases

• Chemotherapy 100%
• Clinical Outcomes 100%
• Clinical Profile 100%
• IgD Myeloma 100%
• Autologous Stem Cell Transplantation (auto-SCT) 100%
• Myeloma 60%
• Partial Response 40%
• Chemotherapy Alone 40%
• Overall Survival 20%
• High Incidence 20%
• Response to Treatment 20%
• Progression-free Survival 20%
• Transplantation 20%
• Poor Outcome 20%
• Patient Cells 20%
• Bone Marrow 20%
• Complete Response 20%
• B-CLL 20%
• Associated Disorders 20%
• Median Overall Survival 20%
• 13q Deletion 20%
• Reticulin 20%
• Interphase Fluorescence in Situ Hybridization 20%
• Complex Karyotype 20%
• Presenting Symptoms 20%
• Bone Pain 20%
• Allogeneic Peripheral Blood Stem Cell Transplantation 20%
• Hairy Cell Leukemia 20%
• Median Progression-free Survival 20%
• Incidence of Complications 20%

Medicine and Dentistry

• Multiple Myeloma 100%
• Myeloma 100%
• Autologous Stem Cell Transplantation 100%
• Immunoglobulin D 100%
• Chemotherapy 100%
• Overall Survival 33%
• Progression Free Survival 33%
• Chronic Lymphocytic Leukemia 16%
• Fluorescence in Situ Hybridization 16%
• Karyotype 16%
• Interphase 16%
• Reticulin 16%
• Bone Pain 16%
• Autologous Peripheral Blood Stem Cell Transplantation 16%
• Hairy Cell Leukemia 16%
• Median Follow Up 16%

Immunology and Microbiology

• Multiple Myeloma 100%
• Autologous Stem Cell Transplantation 100%
• Immunoglobulin D 100%
• Overall Survival 40%
• Progression Free Survival 40%
• Fluorescence in Situ Hybridization 20%
• Leukemia Cell 20%
• Interphase 20%
• Karyotype 20%
• Autologous Peripheral Blood Stem Cell Transplantation 20%